Heard JM - Search Results

1

Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus.

Favre D, Blouin V, Provost N, Spisek R, Porrot F, Bohl D, Marmé F, Chérel Y, Salvetti A, Hurtrel B, Heard JM, Rivière Y, Moullier P. Favre D, et al. Among authors: heard jm. J Virol. 2002 Nov;76(22):11605-11. doi: 10.1128/jvi.76.22.11605-11611.2002. J Virol. 2002. PMID: 12388721 Free PMC article.

2

Human alpha-iduronidase gene transfer mediated by adeno-associated virus types 1, 2, and 5 in the brain of nonhuman primates: vector diffusion and biodistribution.

Ciron C, Cressant A, Roux F, Raoul S, Cherel Y, Hantraye P, Déglon N, Schwartz B, Barkats M, Heard JM, Tardieu M, Moullier P, Colle MA. Ciron C, et al. Among authors: heard jm. Hum Gene Ther. 2009 Apr;20(4):350-60. doi: 10.1089/hum.2008.155. Hum Gene Ther. 2009. PMID: 19272011

3

Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts.

Bohl D, Naffakh N, Heard JM. Bohl D, et al. Among authors: heard jm. Nat Med. 1997 Mar;3(3):299-305. doi: 10.1038/nm0397-299. Nat Med. 1997. PMID: 9055857

4

Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector.

Bohl D, Salvetti A, Moullier P, Heard JM. Bohl D, et al. Among authors: heard jm. Blood. 1998 Sep 1;92(5):1512-7. Blood. 1998. PMID: 9716577 Free article.

5

Mechanisms leading to sustained reversion of beta-thalassemia in mice by doxycycline-controlled Epo delivery from muscles.

Samakoglu S, Bohl D, Heard JM. Samakoglu S, et al. Among authors: heard jm. Mol Ther. 2002 Dec;6(6):793-803. doi: 10.1006/mthe.2002.0810. Mol Ther. 2002. PMID: 12498775 Free article.

6

Modulation of erythropoietin delivery from engineered muscles in mice.

Bohl D, Heard JM. Bohl D, et al. Among authors: heard jm. Hum Gene Ther. 1997 Jan 20;8(2):195-204. doi: 10.1089/hum.1997.8.2-195. Hum Gene Ther. 1997. PMID: 9017423

7

Delivering erythropoietin through genetically engineered cells.

Bohl D, Heard JM. Bohl D, et al. Among authors: heard jm. J Am Soc Nephrol. 2000 Nov;11 Suppl 16:S159-62. J Am Soc Nephrol. 2000. PMID: 11065350 Review.

8

Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef.

Schwartz O, Rivière Y, Heard JM, Danos O. Schwartz O, et al. Among authors: heard jm. J Virol. 1993 Jun;67(6):3274-80. doi: 10.1128/JVI.67.6.3274-3280.1993. J Virol. 1993. PMID: 8497051 Free PMC article.

9

Transcriptional modulation of foreign gene expression in engineered somatic tissues.

Bohl D, Heard JM. Bohl D, et al. Among authors: heard jm. Cell Biol Toxicol. 1998 Mar;14(2):83-94. doi: 10.1023/a:1007480419685. Cell Biol Toxicol. 1998. PMID: 9553719 Review.

10

Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle.

Bohl D, Bosch A, Cardona A, Salvetti A, Heard JM. Bohl D, et al. Among authors: heard jm. Blood. 2000 May 1;95(9):2793-8. Blood. 2000. PMID: 10779423 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters